多种天然产物因其具有抗氧化、抗炎和抗癌活性而被广泛用于化学预防治疗。在本研究中，我们揭示了苜蓿种子发芽第 5 天的芽，并评估了它们的 HDAC 抑制和抗氧化活性。对种子和芽苗的提取物进行提取，并通过 LC-MS/MS、FTIR 和 NMR 进行表征，揭示其化学成分，特别是百里香酚 (THY) 和百里醌 (TQ)。肝细胞癌（HCC）是一种全球健康问题，因为它是一种主要的生活方式疾病。因此，将草药治疗化合物纳入日常生活已成为预防肝病的一种有吸引力的选择。组蛋白脱乙酰酶 (HDAC) 抑制 (HDACi) 正在成为治疗包括 HCC 在内的各种癌症的一种有前景的治疗策略。因此，N. sativa 的第 5 天可以通过抑制 HDAC 活性作为潜在的抗癌剂，因为据报道它在氧化应激的管理中具有重要作用。与标准药物 (Trichostatin A) 和百里酚相比，苜蓿的生物活性化合物（即百里醌）也显示出与 HDAC 蛋白 (3MAX) 良好的结合亲和力，并在计算机研究中具有稳定的相互作用。由 Ramaswamy H 通讯.萨尔玛。

A wide variety of natural products have been widely used in chemoprevention therapy because they have antioxidant, anti-inflammatory, and anticancer activity. In the present study, we shed light on the 5th day germinated sprouts of N. sativa seeds and evaluated them against HDAC inhibition and antioxidant activity. The extract from the seed and sprout was extracted and characterised by LC-MS/MS, FTIR, and NMR to reveal its chemical composition, especially thymol (THY) and thymoquinone (TQ). Hepatocellular carcinoma (HCC) is a global health concern as it is a major lifestyle disease. Hence, incorporating herbal-based therapeutic compounds into everyday routines has become an attractive alternative for preventing hepatic diseases. Histone deacetylase (HDAC) inhibition (HDACi) is emerging as a promising therapeutic strategy for managing various carcinomas including HCC. Therefore, the 5th day of N. sativa can be used as a potential anticancer agent by inhibiting HDAC activity, as it is reported to have an important role in the management of oxidative stress. The bioactive compound of N. sativa, i.e. thymoquinone, also showed a good binding affinity with the HDAC protein (3MAX) with a stable interaction in an in silico study as compared to the standard drug (Trichostatin A) and thymol.Communicated by Ramaswamy H. Sarma.